Farwell D J, Sulke A N
Department of Cardiology, Eastbourne District General Hospital, King's Drive, Eastbourne, East Sussex, UK.
Int J Cardiol. 2005 Dec 7;105(3):241-9. doi: 10.1016/j.ijcard.2004.10.066. Epub 2005 Jul 12.
Head-up tilt testing is an important tool in the diagnosis of syncope. Several different protocols are in use. This study aimed to compare three different protocols in an unselected population of patients with recurrent unexplained syncope and to assess long-term outcome using conventional tilt-directed management or implantable loop recorder (Reveal Plus)-directed management, allowing evaluation of the sensitivity and specificity of the technique.
Patients with recurrent unexplained syncope were randomized to one of three tilt protocols: Drug-free--70 degree tilt, 45 min, CSM at 5 and 45 min. GTN--70 degree tilt, 35 min, CSM at 5 min, 400 microg of glyceryl trinitrate spray administered sublingually at 20 min. Adenosine--70 degree tilt, 5 min, CSM when blood pressure is stable in upright position, adenosine bonus at 150 microg/kg after CSM. Tilts were terminated at the onset of syncope, when systolic BP reached 60 mm Hg, or in the presence of prolonged hypotension (> 3 min systolic BP < 80 mm Hg). Appropriate therapies were commenced according to the result of the tilt test. All patients without a definite indication for immediate cardiac pacing (asystolic tilt) were randomized to conventional management or ILR implantation. Recurrent syncopal events were compared to tilt outcome, allowing estimation of sensitivity and specificity.
Of 214 patients, aged 68+/-18 years, 55% were female, with a median of three previous syncopes. 13 patients received pacemakers due to asystolic syncope during tilt testing. The proportion of VASIS classification diagnoses was similar with each protocol; however more positive diagnoses resulted from the GTN protocol (p=0.0013). 47% of patients achieved a diagnosis with tilt testing. We were able to correlate a subsequent spontaneous syncope to tilt result in 36 patients (18%). Heart rate during a spontaneous event was similar to that obtained during tilt testing (+/- 10%) in 55% of cases. Sensitivities for combined protocols, adenosine, GTN, and drug-free protocols were 50%, 50%, 100%, and 21%, respectively. Specificities were 85%, 100%, 75%, and 71%, respectively.
A high diagnosis rate for unexplained syncope can be achieved with tilt testing. The GTN protocol resulted in significantly more diagnoses than the other compared protocols with good sensitivity and adequate specificity. Sensitivity of the drug-free tilt test was lower than drug-augmented tilt testing.
头高位倾斜试验是晕厥诊断的一项重要工具。目前有几种不同的方案在使用。本研究旨在比较三种不同方案在未经选择的复发性不明原因晕厥患者群体中的效果,并使用传统的倾斜试验指导管理或植入式循环记录仪(Reveal Plus)指导管理来评估长期结果,从而评估该技术的敏感性和特异性。
复发性不明原因晕厥患者被随机分为三种倾斜试验方案之一:无药——70度倾斜,45分钟,在5分钟和45分钟时进行颈动脉窦按摩(CSM)。硝酸甘油——70度倾斜,35分钟,在5分钟时进行CSM,在20分钟时舌下给予400微克硝酸甘油喷雾剂。腺苷——70度倾斜,5分钟,在直立位血压稳定时进行CSM,在CSM后给予150微克/千克的腺苷追加剂量。当出现晕厥、收缩压达到60毫米汞柱或出现持续性低血压(收缩压<80毫米汞柱超过3分钟)时终止倾斜试验。根据倾斜试验结果开始适当的治疗。所有无立即心脏起搏明确指征(心脏停搏性倾斜)的患者被随机分为传统管理组或植入ILR组。将复发性晕厥事件与倾斜试验结果进行比较,以估计敏感性和特异性。
214例患者,年龄68±18岁,55%为女性,既往晕厥中位数为3次。13例患者因倾斜试验期间心脏停搏性晕厥接受了起搏器治疗。每种方案的VASIS分类诊断比例相似;然而,硝酸甘油方案导致的阳性诊断更多(p = 0.0013)。47%的患者通过倾斜试验获得了诊断。我们能够将36例患者(18%)随后的自发性晕厥与倾斜试验结果相关联。在55%的病例中,自发性事件期间的心率与倾斜试验期间获得的心率相似(±10%)。联合方案、腺苷、硝酸甘油和无药方案的敏感性分别为50%、50%、100%和21%。特异性分别为85%、100%、75%和71%。
倾斜试验可实现较高的不明原因晕厥诊断率。硝酸甘油方案导致的诊断明显多于其他比较方案,具有良好的敏感性和足够的特异性。无药倾斜试验的敏感性低于药物增强倾斜试验。